Mechanisms	0	10	O
of	11	13	O
pericyte	14	22	B-Cell
recruitment	23	34	O
in	35	37	O
tumour	38	44	B-Pathological_formation
angiogenesis	45	57	O
:	57	58	O
a	59	60	O
new	61	64	O
role	65	69	O
for	70	73	O
metalloproteinases	74	92	B-Gene_or_gene_product
.	92	93	O

Pericytes	95	104	B-Cell
occur	105	110	O
in	111	113	O
tumour	114	120	B-Multi-tissue_structure
blood	121	126	I-Multi-tissue_structure
vessels	127	134	I-Multi-tissue_structure
and	135	138	O
are	139	142	O
critical	143	151	O
for	152	155	O
the	156	159	O
development	160	171	O
of	172	174	O
a	175	176	O
functional	177	187	O
vascular	188	196	B-Multi-tissue_structure
network	197	204	I-Multi-tissue_structure
.	204	205	O

Targeting	206	215	O
tumour	216	222	B-Cell
pericytes	223	232	I-Cell
is	233	235	O
a	236	237	O
promising	238	247	O
anti	248	252	O
-	252	253	O
angiogenic	253	263	O
therapy	264	271	O
but	272	275	O
requires	276	284	O
identifying	285	296	O
the	297	300	O
mechanisms	301	311	O
of	312	314	O
their	315	320	O
recruitment	321	332	O
in	333	335	O
tumour	336	342	B-Pathological_formation
and	343	346	O
addressing	347	357	O
whether	358	365	O
these	366	371	O
mechanisms	372	382	O
can	383	386	O
be	387	389	O
selectively	390	401	O
harnessed	402	411	O
.	411	412	O

Among	413	418	O
the	419	422	O
pathways	423	431	O
involved	432	440	O
in	441	443	O
pericyte	444	452	B-Cell
recruitment	453	464	O
during	465	471	O
embryonic	472	481	O
development	482	493	O
,	493	494	O
the	495	498	O
contribution	499	511	O
of	512	514	O
platelet	515	523	B-Gene_or_gene_product
-	523	524	I-Gene_or_gene_product
derived	524	531	I-Gene_or_gene_product
growth	532	538	I-Gene_or_gene_product
factor	539	545	I-Gene_or_gene_product
B	546	547	I-Gene_or_gene_product
and	548	551	O
sphingosine	552	563	B-Gene_or_gene_product
1	564	565	I-Gene_or_gene_product
-	565	566	I-Gene_or_gene_product
phosphate	566	575	I-Gene_or_gene_product
is	576	578	O
confirmed	579	588	O
in	589	591	O
tumour	592	598	B-Pathological_formation
angiogenesis	599	611	O
.	611	612	O

The	613	616	O
effect	617	623	O
of	624	626	O
angiopoietin	627	639	B-Gene_or_gene_product
1	640	641	I-Gene_or_gene_product
depends	642	649	O
on	650	652	O
the	653	656	O
tumour	657	663	B-Pathological_formation
model	664	669	O
.	669	670	O

Transforming	671	683	B-Gene_or_gene_product
growth	684	690	I-Gene_or_gene_product
factor	691	697	I-Gene_or_gene_product
-	697	698	I-Gene_or_gene_product
beta1	698	703	I-Gene_or_gene_product
enhances	704	712	O
tumour	713	719	B-Pathological_formation
vascularization	720	735	O
and	736	739	O
microvessel	740	751	B-Tissue
maturation	752	762	O
.	762	763	O

Recent	764	770	O
reports	771	778	O
suggest	779	786	O
a	787	788	O
participation	789	802	O
of	803	805	O
matrix	806	812	B-Gene_or_gene_product
metalloproteinases	813	831	I-Gene_or_gene_product
(	832	833	O
MMP	833	836	B-Gene_or_gene_product
)	836	837	O
in	838	840	O
tumour	841	847	B-Cell
pericyte	848	856	I-Cell
recruitment	857	868	O
that	869	873	O
is	874	876	O
consistent	877	887	O
with	888	892	O
the	893	896	O
effect	897	903	O
of	904	906	O
certain	907	914	O
MMPs	915	919	B-Gene_or_gene_product
in	920	922	O
the	923	926	O
development	927	938	O
of	939	941	O
microvasculature	942	958	B-Multi-tissue_structure
in	959	961	O
embryonic	962	971	O
development	972	983	O
and	984	987	O
in	988	990	O
in	991	993	O
vitro	994	999	O
models	1000	1006	O
of	1007	1009	O
vascular	1010	1018	B-Multi-tissue_structure
remodelling	1019	1030	O
.	1030	1031	O

Here	1032	1036	O
,	1036	1037	O
we	1038	1040	O
discuss	1041	1048	O
the	1049	1052	O
possibility	1053	1064	O
for	1065	1068	O
MMPs	1069	1073	B-Gene_or_gene_product
to	1074	1076	O
contribute	1077	1087	O
to	1088	1090	O
pericyte	1091	1099	B-Cell
recruitment	1100	1111	O
at	1112	1114	O
six	1115	1118	O
levels	1119	1125	O
:	1125	1126	O
(	1127	1128	O
1	1128	1129	O
)	1129	1130	O
direct	1131	1137	O
promotion	1138	1147	O
of	1148	1150	O
pericyte	1151	1159	B-Cell
invasion	1160	1168	O
by	1169	1171	O
extracellular	1172	1185	B-Cellular_component
matrix	1186	1192	I-Cellular_component
degradation	1193	1204	O
;	1204	1205	O
(	1206	1207	O
2	1207	1208	O
)	1208	1209	O
stimulation	1210	1221	O
of	1222	1224	O
pericyte	1225	1233	B-Cell
proliferation	1234	1247	O
and	1248	1251	O
protection	1252	1262	O
against	1263	1270	O
apoptosis	1271	1280	O
by	1281	1283	O
modification	1284	1296	O
of	1297	1299	O
the	1300	1303	O
ECM	1304	1307	B-Cellular_component
;	1307	1308	O
(	1309	1310	O
3	1310	1311	O
)	1311	1312	O
activation	1313	1323	O
of	1324	1326	O
pericytes	1327	1336	B-Cell
through	1337	1344	O
the	1345	1348	O
release	1349	1356	O
of	1357	1359	O
growth	1360	1366	O
factor	1367	1373	O
bound	1374	1379	O
to	1380	1382	O
the	1383	1386	O
ECM	1387	1390	B-Cellular_component
;	1390	1391	O
(	1392	1393	O
4	1393	1394	O
)	1394	1395	O
transactivation	1396	1411	O
of	1412	1414	O
angiogenic	1415	1425	O
cell	1426	1430	O
surface	1431	1438	O
receptor	1439	1447	O
;	1447	1448	O
(	1449	1450	O
5	1450	1451	O
)	1451	1452	O
propagation	1453	1464	O
of	1465	1467	O
angiogenic	1468	1478	O
signalling	1479	1489	O
as	1490	1492	O
cofactor	1493	1501	O
;	1501	1502	O
and	1503	1506	O
(	1507	1508	O
6	1508	1509	O
)	1509	1510	O
recruitment	1511	1522	O
of	1523	1525	O
bone	1526	1530	B-Cell
marrow	1531	1537	I-Cell
-	1537	1538	I-Cell
derived	1538	1545	I-Cell
stem	1546	1550	I-Cell
cells	1551	1556	I-Cell
.	1556	1557	O

